Catalyst Wire Dossier Catalyst Wire Dossier

RGX-202

· REGENXBIO Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RGX-202, covering 2025-12-17 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-up for RGX-202

See pricing